This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Desmopressin Acetate

Read time: 1 mins
Marketing start date: 23 Nov 2024

Summary of product characteristics


Effective Time

20221031

Version

5

Spl Product Data Elements

Desmopressin Acetate Desmopressin Acetate DESMOPRESSIN ACETATE DESMOPRESSIN SODIUM CHLORIDE CITRIC ACID MONOHYDRATE SODIUM PHOSPHATE, DIBASIC, DIHYDRATE BENZALKONIUM CHLORIDE WATER

Application Number

ANDA091345

Brand Name

Desmopressin Acetate

Generic Name

Desmopressin Acetate

Product Ndc

70771-1314

Product Type

HUMAN PRESCRIPTION DRUG

Route

NASAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1314-1 Desmopressin Acetate Nasal Solution (Nasal Spray), 10 mcg/ 0.1 mL per spray 5 mL Rx only Image

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.